SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016138
Filing Date
2021-11-17
Accepted
2021-11-17 16:01:25
Documents
12
Period of Report
2021-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20211115x8k.htm   iXBRL 8-K 32076
  Complete submission text file 0001558370-21-016138.txt   149634

Data Files

Seq Description Document Type Size
2 EX-101.SCH imgn-20211115.xsd EX-101.SCH 2986
3 EX-101.LAB imgn-20211115_lab.xml EX-101.LAB 16755
4 EX-101.PRE imgn-20211115_pre.xml EX-101.PRE 9902
5 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20211115x8k_htm.xml XML 4694
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 211420560
SIC: 2834 Pharmaceutical Preparations